Global clinical trials outsourcing market to double by 2035: TMR
DELAWARE, UNITED STATES — The worldwide clinical trial outsourcing market is expected to experience significant growth over the next decade, with its value projected to increase more than twice from US$50.7 billion in 2024 to US$101.9 billion by 2035, according to recent research by Transparency Market Research (TMR).
The study specifies that the increasing intricacy of clinical investigations and the growing need for economical and technology-based solutions are the primary reasons leading the pharmaceutical and biotech industries to rely more heavily on contract research organizations (CROs) and specialized service providers.
Digital transformation reshaping clinical research
The outsourcing of clinical research has become a strategic necessity for companies in the life sciences sector, enabling them to accelerate drug development while navigating the complex maze of regulatory standards and global patient recruitment.
TMR stated that the clinical trial data management service is the largest market, reflecting the increasing need for secure, instant, and high-quality data handling in the digital era.
“Pharmaceutical and biotechnology companies are under increasing pressure to reduce operational costs and accelerate time-to-market for novel therapies,” said TMR analysts.
A TMR analyst remarked that outsourcing opens up companies’ access to the most sophisticated digital infrastructure, AI-powered analytics, as well as skilled staff, without the associated costs of keeping those resources in-house.
With the advent of electronic data capture (EDC) systems, cloud-based platforms, and real-time data monitoring, CROs have completely altered the way sponsors collect and analyze huge amounts of clinical data. The report has also indicated the growing adoption of AI, blockchain, and automation.
Technology and trust at the core
This surge in clinical trial outsourcing reflects broader trends across the global outsourcing sector, where the adoption of technology and operational agility is reshaping business models.
As seen in the IT and business process outsourcing (BPO) industries, the future of healthcare outsourcing lies in a hybrid model that blends AI-driven efficiency with human expertise. While automation enhances precision, the credibility and trust built by specialized teams remain central to the industry’s long-term success, a balance that the clinical research industry must maintain.
